Skip to content
Recall Observatory FDA recall evidence

Drug product

Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepally - 500 090 India; NDC 55111-180-15.

D-238-2013

March 19, 2013

Class III

Product summary

Firm
Dr. Reddy'S Laboratories
Event
Event 64733
Status
Terminated
Classification
Class III
Quantity
117,546 bottles
Official record key
drug-enforcement:D-238-2013

Official wording

Reason: Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.

Code information: Lot #: C208625, C208984, C209113, C209369, Exp 09/15; and C209680, Exp 10/15.

Distribution pattern: Nationwide and Puerto Rico.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.

Field note

Send feedback

We'll only use this to respond to your feedback.